Return to search

Leiden Joins Millennium Pharma Board

Jeffrey Leiden, a managing director with Clarus Ventures, has joined the board of directors with Millennium Pharmaceuticals Inc. (Nasdaq: MLNM). Prior to joining Clarus, Leiden had served as president and COO of Abbott Labs' global pharmaceuticals business. www.millennium.com